Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Myelin-oligodendrocyte glycoprotein antibody-associated disease

Marignier R. et al, (2021), The Lancet Neurology, 20, 762 - 772

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases

Schanda K. et al, (2021), Neurology(R) neuroimmunology & neuroinflammation, 8

Frequency of MOG-IgG in cerebrospinal fluid versus serum

Pace S. et al, (2021), Journal of Neurology, Neurosurgery and Psychiatry

Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence.

Soares-Dos-Reis R. et al, (2021), Mult Scler Relat Disord, 53

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.

Messina S. et al, (2021), Mult Scler

Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis.

Juryńczyk M. et al, (2021), J Neurol

No strong HLA association with MOG antibody disease in the UK population.

Grant-Peters M. et al, (2021), Ann Clin Transl Neurol

High incidence of NMDAR encephalitis among Austronesians: A population-based study in Sabah, Malaysia.

Wong CK. et al, (2021), J Neuroimmunol, 356

Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis.

Howard JF. et al, (2021), Expert Opin Investig Drugs, 1 - 11

Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.

Binks SNM. et al, (2021), JAMA Neurol

Pregnancy in Patients With AQP4-Ab, MOG-Ab or Double-Negative Neuromyelitis Optica Disorder.

Collongues N. et al, (2021), Neurology

Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.

Mariano R. et al, (2021), Brain, 144, 198 - 212

Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.

Leite MI., (2021), Neurology, 96, 294 - 295

Foveal changes in AQP4-Ab seropositive NMOSD are independent of optic neuritis and not overtly progressive.

Roca-Fernández A. et al, (2021), Eur J Neurol

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.

Messina S. et al, (2021), Mult Scler Relat Disord, 49

MuSK Antibody-Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report.

Muhammed L. et al, (2021), Ann Intern Med

Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).

Specovius S. et al, (2020), BMJ Open, 10

A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis.

Li V. et al, (2020), Neurology

Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease.

Dos Passos GR. et al, (2020), J Neurol Sci, 415

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis.

Sá MJ. et al, (2020), Neurol Ther

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?